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1792-31 Differentiallmpaet of Stent versus PTCA on
Restenosis in Large (~3 mm) and Small «3 mm)
Vessels in the STent REStenosis Study
S. Chiu Wong, John Hirshfeld, Paul Teirstein, Richard Schatz, Alex Shaknovich,
Masakiyo Nobuyoshi, Lowell F. Saller, Ya Chien Chuang, Martin B. Leon
Washington Hospital Center, Washington, DC
To determine the impact of reference vessel size on restenosis (RES) in the
multicenter randomized STent REStenosis Study ISTRESS), we compared
stent (S) vs PTCA in large 12:3 mm by ImageComm quantitative angiographic
edge detection methods) and small «3 mm) vessels.
S~3mm PTCA,,:3 mm S <3mm PTCA <3 mm
N ~ 102 N = 90 N = 102 N = 111
Final % stenosis 20 ± 10 34±l1 t 17 ± 13 36 ± 17t
Acute gain (mm) 1.86 ± 0.44 1.39 ± 0.52' 1.58 ± 0.44 1.10 ± 0.40t
Late loss (mml 0.71 ± 058 0.38 ± 0.60" 0.78 ± 055 0.49 ± 0.53**
Net gain (mm) 1.11 ± 0.62 0.98 ± 0.65 0.85 ± 059 0.63 ± 0.53*
RES (>50% stenosis) 25.6 28.9 356 52.4*
*p < 0.05, **p < 0.001, tp < 0.0001 compared PTCA with S
For large and small vessels, S (compared to PTCA) had greater acute gain
due to lower final % stenosis but S also had greater late loss. Nevertheless,
net gain was still greater in S pts resulting in lower RES (vs PTCA). Late angio-
graphic responses to Sand PTCA were different in large and small vessels;
S had similar late loss irrespective of vessel size, whereas PTCA had less
late loss in 2:3 mm vessels which partially neutralizes the acute gain benefit
of S. Thus, although RES was generally lower in 2:3 mm vessels, there was
little difference among Sand PTCA pts. In <3 mm vessel, absolute RES was
higher and there was a marked difference in RES between Sand PTCA. Im-
portantly, late clinical events showed a similar differential response; target
lesion revascularization (CABG or repeat PTCA) was similar for Sand PTCA
in 2:3 mm vessels (15 vs 13%, NS) but in <3 mm vessels was lower in S pts
(22 vs 32%, P = 0.1). In conclusion: Data from STRESS indicate that S had a
greater impact on lowering RES and increasing clinical benefit in smaller «3
mm) vs larger (2:3 mm) vessels. Future designs efforts should be directed
towards developing a smaller S which can be safely implanted in smaller
coronary vessels,
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1792-41 Three Years Clinical and Quantitative Angiographic
Follow-up After the Palmaz-Schatz Coronary Stent
Implantation
Takeshi Kimura, Hiroyoshi Yokoi, Takashi Tamura, Yoshihisa Nakagawa,
Hideyuki Nosaka, Masakiyo Nobuyoshi. Kokura Memorial Hospital, Kitakyushu, Japan
Despite its proven efficacy in reducing restenosis in selected lesions, one of
the greatest uncertainties of coronary stenting is longer-term results associ-
ated with permanent placement of metallic prosthetic devices. To evaluate
efficacy and safety in long-term, a prospective serial angiographic study at
6 months (mos). 1 year (yr) and 3 yrs was designed. Between June 1990 to
July 1991, single Palmaz-Schatz stent implantation for native coronary arter-
ies was successful in 94 patients (pts) (age: 63 ± 9, male 77%, multivessel
disease: 49%) or97 lesions (Ies)(LAD: 51 %, RCA: 34%, Cx: 7%, LMCA: 8%,
restenotic lesion: 54%, bail-out use: 24%). At 3 yrs, 93% of pts were alive,
88% free from death/MI/CABG and 79% free from death/MI/CABGltarget le-
sion revascularization (TLR). Six mos follow-up angiography (FUA) was per-
formed and cine films were available in 88 pts (94%). Nine pts (9.6%1 under-
went TLR and 3 pts died (cardiac: 1, non-cardiac: 2) within 12 mos. Excluding
these 12 pts, 82 pts (85 les) were eligible for longer-term FU. FUA at 1 and 3
yrs was performed in 73 pts (89%), and 49 pts (60%). respectively. CMS II
was used for quantitative analysis.
Pre Post 6 mes 1yr 3 yrs
N of les 52 52 52 52 52
Interval (days) 193 ± 21 374 ± 24 1068 ± 105
MLD(mm) 1.00 ± 0.42 256 ± 05 198 ± 053 197 ± 0.52 2.12±053
Ref(mm} 3.15 ± 0.58 3.42 ± 06 306 ± 0.6 3.07 ± 056 312 ± 056
MLD = minimal lumen diameter, Ref = Interpolated reference diameter
MLD improved between 6 mos and 3 yrs (P = 0.016) and did not change
between 6 mos and 1 yr. Clinical events beyond 1 yrwas analyzed in pts with
or without FUA at 3 yrs. In 49 pts with FUA at 3 yrs, 2 pts (4%) suffered from
MI unrelated to the stented les. TLR and PTCA for new les were required in
2 pts (4%) and 9 pts (18%) respectively. In 33 pts without FUA at 3 yrs, 3 pts
(9%) died from definite non-cardiac causes and 2 pts (6%) underwent TLR
due to angiographic restenosis at 1 yr FUA. In conclusion, safety and efficacy
of stents appeared to be sustained at 3 yrs.
ABSTRACTS 375A
3:15
1792-51 Three Year Follow-up After Intracoronary Stent
Implantation
Bruce D. Klugherz, Back K. Kim, Debra L. DeAngelo, Howard C. Herrmann, John
W Hirshfeld, Jr., Daniel M. Kolansky University of Pennsylvania, Philadelphia, PA
To identify predictors of long-term success following intracoronary stenting,
we analyzed clinical outcome in 65 consecutive patients who electively re-
ceived Palmaz-Schatz stents at least 3 years prior to analysis. 83 stents were
successfully inserted in 63 of 65 patients (97%). of whom 49 (75%) were
men and 16 (25%) were women, with a mean age (±SD) of 59 ± 9 years,
18 patients (28%) were diabetic. 16 patients (24%) required more than one
stent. Indications for stenting included restenosis following prior PTCA (52%)
and lesion complexity (43%). 10 patients (15%) received stents in saphenous
vein grafts,
Demographic, clinical, and procedural predictors of survival and event-free
survival at a mean follow-up of 39 ± 17 months were analyzed. Event-free
survival was defined as survival without MI, CABG, PTCA at the stent site, or
recurrent target vessel ischemia. Survival and event-free survival at 3 years
were 86% and 54%, respectively. Predictors of decreased long term survival
(p < 0.05) included diabetes, and a high angina score (Canadian Heart Class
3-4) at 6 and 12 months follOWing stenting. Predictors of decreased event-
free survival (p < 0.05) included smaller balloon size at implantation, greater
number of stents at the primary lesion, and high angina score at each follow-
up interval. Freedom from adverse events by 6 months following stenting
correlated with long term success. 35 of 44 patients (80%) with event-free
survival at 6 months remained event-free at follow-up. During follow-up, 17
patients (27%) developed symptomatic stent restenosis, requiring primarily
early revascularization; 18 patients (28%) developed symptomatic stenoses
in other vessels, requiring primarily late revascularization,
We conclude that: (1) long term survival after stenting is excellent; (2) the
need for late revascularization is dictated primarily by disease progression in
non-stented vessels; and (3) long-term success of stenting is predicted by
freedom from adverse events at 6 months.
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1792-61 Late Lesion Regression within the Gianturco-Roubin
Flex-Stent
James B. Hermiller, Edward T. Fry, Thomas F. Peters, Charles M. Orr, James Van
Tassel, Belinda Ness, Cass A. Pinkerton St. Vincent Hospital, Indianapolis, IN
The late angiographic outcome of the Gianturco-Roubin (GR) intracoronary
stent is not well defined. To investigate serial changes within the stent, we
studied 13 patients (9 men, 4 women; mean age 63) status-post GR stenting,
who had acute, 6-month, and chronic (C) (> 12 month) angiographic follow-
up without intervening PTCA. Single stents were inserted in 11 patients and
double stents in two, Average time to chronic follow-up was 21 months. Elec-
tronic calipers were used to determine pre, post, 6-mo, and chronic stent
and coronary dimensions, which included MLD (minimum lumen diameter).
% sten (% diameter stenosis). and REF (reference dimension). Data are ex-
pressed as mean ± 1 SO.
Results:
MLD(mm) % Sten REF (mm)
Pre 095 ± 12 69±6'10 28±0.17
Post 2.3 ± 016 20± 5% 2.9 ± 014
6mo 16 ± 015 39±6% 2.6 ± 013
C 2.1 ± 013* 23 ± 4%* 27 ± 015
*P< 0.05 CVS. 6-mo
No patient had a significant decline in MLD or an increase in % stenosis at
C vs. 6 months. Five had a greater than 50% increase in MLD at C.
Conclusion: Long term follow-up demonstrates late lesion regression,
which is sometimes dramatic within the GR stent. These data have important
clinical implications and suggest that coronary arteriography at 6-months
may underestimate the chronic angiographic benefit of the intracoronary
Gianturco-Roubin Flex-Stent.
